CHARLESTON, S.C. (WCIV) — MUSC is leading the country in a clinical trial testing a new cochlear implant. Doctors at MUSC say they are the only site on the east coast who are part of the ...

The fully implanted Acclaim® cochlear implant received Breakthrough Device Designation from the FDA in 2019 and was first implanted in three participants during an early feasibility study (EFS) at ...

Delray Beach, FL, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The global cochlear implants market valued at US$2.58 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$2.80 Billion in ...

The Medical University of South Carolina in Charleston will be the first clinical trial site in the country to test a new ...

The Medical University of South Carolina in Charleston is set to be the first clinical trial site in the country to test a new cochlear implant for people with hearing loss.

The fourth grader was referred to a specialist in Lexington, who discovered he was a good candidate for a new type of ...

DELRAY BEACH, Fla., Feb. 7, 2025 /PRNewswire/ -- The cochlear implants market valued at US$ 2.58 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 2.80 Billion in 2024 ...

Synchrony currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following ...